Neuroprotective effect and mechanism of cPLA2 inhibitor increases autophagic flux on spinal cord injury.
10.12200/j.issn.1003-0034.2023.09.015
- Author:
Wen-Hai YAN
1
;
Ming-Sheng TAN
2
;
Cheng HUANG
2
;
Nan-Shan MA
2
;
Xiang-Sheng TANG
2
Author Information
1. Beijing University of Traditional Chinese Medicine, Beijing 100029, China.
2. Department of Spine Surgery of Orthopedics, China-Japan Friendship Hospital, Beijing 100029, China.
- Publication Type:Journal Article
- Keywords:
Autophagy flux;
Cytosolic phospholipase A2;
Inhibitor;
Mechanism;
Spinal cord injury
- MeSH:
Female;
Animals;
Rats;
Rats, Sprague-Dawley;
Neuroprotective Agents/pharmacology*;
Spinal Cord Injuries/drug therapy*;
Spinal Cord Compression
- From:
China Journal of Orthopaedics and Traumatology
2023;36(9):873-879
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the mechanism of cytosolic phospholipase A2(cPLA2) inhibitor to improve neurological function after spinal cord injury (SCI).
METHODS:Thirty-six 3 months old female SD rats, with body mass (280±20) g, were divided into three groups (n=12):sham group, SCI group, and SCI+ arachidonyl trifluoromethyl ketone(AACOCF3) group. Balloon compression SCI model was established in all three groups. In the sham model group, the spinal cord compression model was created after the balloon was placed without pressure treatment, and the remaining two groups were pressurized with the balloon for 48 h. After successful modeling, rats in the SCI+AACOCF3 group were injected intraperitoneally with AACOCF3, a specific inhibitor of cPLA2. The remaining two groups of rats were injected intraperitoneally with saline. The animals were sacrificed in batches on 7 and 14 days after modeling, respectively. And the damaged spinal cord tissues were sampled for pathomorphological observation, to detect the expression of cPLA2 and various autophagic fluxPrelated molecules and test the recovery of motor function.
RESULTS:Spinal cord histomorphometry examination showed that the spinal cord tissue in the sham group was structurally intact, with normal numbers and morphology of neurons and glial cells. In the SCI group, spinal cord tissue fractures with large and prominent spinal cord cavities were seen. In the SCI+AACOCF3 group, the spinal cord tissue was more intact than in the SCI group, with more fused spinal cord cavities, more surviving neurons, and less glial cell hyperplasia. Western blot showed that the sham group had the lowest protein expression of LC3-Ⅱ, Beclin 1, p62, and cPLA2 compared with the SCI and SCI+AACOCF3 groups (P<0.05) and the highest protein expression of LC3-Ⅰ (P<0.05). P62 and cPLA2 expression in the SCI group were higher than in the SCI+AACOCF3 group (P<0.05). Behavioral observations showed that the time corresponding to BBB exercise scores was significantly lower in both the SCI and SCI+AACOCF3 groups than in the sham group (P<0.05). Scores at 3, 7, and 14 days after pressurization were higher in the SCI+AACOCF3 group than in the SCI group (P<0.05).
CONCLUSION:cPLA2 inhibitors can reduce neuronal damage secondary to SCI, promote neurological recovery and improve motor function by improving lysosomal membrane permeability and regulating autophagic flux.
